As the global synthetic biology market prepares for annual growth exceeding 17% through 2030, Integrated DNA Technologies (IDT) is expanding its role in the...
Integrated DNA Technologies (IDT) has entered into a licensing agreement with SeQure Dx, a specialist in off-target analysis for gene modification.
According to a release,...
IDT and Aldevron, two leading CRISPR gene editing companies, today announced a strategic partnership to expand key CRISPR solutions for cell and gene therapy...